CompuGroup Medical SE & Co. KGaA
CMPVF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -2.8% | -1.8% | 3.7% | – |
| Cost of Goods Sold | $0 | $1 | $1 | $1 |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 83.6% | 17.4% | 30.5% | 27.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $0 | $0 |
| Operating Income | $0 | $0 | $0 | $0 |
| % Margin | 9.2% | 14.4% | 11.2% | 12% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 3% | 3.9% | 6.1% | 5.9% |
| EPS | 0.67 | 0.97 | 1.5 | 1.5 |
| % Growth | -30.9% | -35.3% | 0% | – |
| EPS Diluted | 0.67 | 0.97 | 1.5 | 1.48 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 17.9% | 17.9% | 19.5% | 19.7% |